2019 annual financial data
Iovance Biotherapeutics 2019 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -206,872,000 USD and net income was -187,071,000 USD.
Operating cash flow was -158,889,000 USD.
Get free Iovance Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -206,872,000 USD
- Net income
- -187,071,000 USD
- Operating cash flow
- -158,889,000 USD